Table 1.
| ||||
---|---|---|---|---|
OVX | ||||
| ||||
CPP | Self-administration | Seeking | PR Responding | |
Cocaine | ↓ | ↓ | ↓ | - |
Opioids | ↓, ↑ | No effect | No effect | No effect |
| ||||
OVX + estradiol replacement | ||||
| ||||
CPP | Self-administration | Seeking | PR Responding | |
| ||||
Cocaine | ↑ | ↑ | ↑ | ↑ |
Opioids | ↑, No effect | ↑, No effect | ↓, No effect | No effect |
This table summarizes the studies that have examined the role of ovarian hormones in preclinical models of cocaine and opioid use disorder. The rows for each drug reflect changes to behavioral phenotypes following OVX and OVX + estradiol replacement. The line symbolizesthat no studies have examined this directly